Liver Institute Northwest
Kris V. Kowdley MD
Liver Institute Northwest is open for in-person and telemedicine consultations.
We see patients in our Seattle office for clinical consultations as well as clinical research trials. Fully committed to the health and safety of our patients, staff, and greater community, we are closely monitoring the COVID-19 situation and have implemented extensive precautions and procedures to help ensure everyone’s safety. Your health and safety are our top priority, and we will continue to update you as we receive more information.
New Liver News
We are pleased to announce the:
Pacific Northwest GI and Liver Update, September 16-17, 2022
Hyatt Regency Lake Washington, Renton, WA
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
Scott D. Lee, MD
V. Raman Muthusamy, MD, MAS
Register now at:
Kris V. Kowdley MD is recognized on 2021 Highly Cited Researchers list at WSU
WORLD OBESITY DAY March 4, 2022
“Dr. Kowdley will be presenting on liver disease associated with obesity at a symposium in recognition of World Obesity Day to Global Obesity and Liver Disease Research Unit at Novo Nordisk Research Institute”
The mission of the Liver Institute Northwest is to improve the liver health of people in the Pacific Northwest. We bring state-of-the-art treatment and cutting-edge clinical trials offering new therapies for patients with liver disease. Our goal is to increase access for patients to clinical trials and clinical care, advocacy on behalf of patients with liver disease, and evidence-based education on best practices for patients and providers.
We are currently focused on clinical trials in fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hereditary hemochromatosis and chronic hepatitis B and other liver diseases. If you are interested in participating in a clinical trial, please See Our Research Page.